Walleye Trading
RETA

Walleye Trading’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Walleye Trading’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,251
Closed -$146K – 5696
2022
Q2 		$160K Buy
+5,251
New +$157K ﹤0.01% 3860
2022
Q1 		– Sell
-6,965
Closed -$184K – 6084
2021
Q4 		$184K Buy
+6,965
New +$539K ﹤0.01% 3952
2020
Q2 		– Sell
-158
Closed -$24K – 4732
2020
Q1 		$23K Buy
+158
New +$30.5K ﹤0.01% 3612
2019
Q4 		– Sell
-3,594
Closed -$656K – 4726
2019
Q3 		$289K Buy
3,594
+3,554
+8,885% +$302K ﹤0.01% 2621
2019
Q2 		$4K Sell
40
-571
-93% -$49.3K ﹤0.01% 3914
2019
Q1 		$52K Buy
+611
New +$50.7K ﹤0.01% 3705
2018
Q3 		– Sell
-6,492
Closed -$458K – 5631
2018
Q2 		$227K Buy
+6,492
New +$198K ﹤0.01% 3540
2017
Q2 		– Sell
-100
Closed -$2 – 5071
2017
Q1 		$2 Sell
100
-2,100
-95% -$51.9K ﹤0.01% 4551
2016
Q4 		$48K Buy
+2,200
New +$55.6K ﹤0.01% 3663

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Trading's RETA Position: Q3 2022 in Review

Walleye Trading sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2022, closing a stake of 5,251 shares — an estimated $146K sold.

Walleye Trading first reported a position in RETA in Q4 2016 and held it in 9 quarters. The position peaked at $289K in Q3 2019. 159 funds tracked by Wall St. Rank hold RETA as of Q3 2022.

  • Walleye Trading reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 5,251 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2022, an estimated $146K.
  • Walleye Trading first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2016 and held it in 9 quarters.
  • Walleye Trading's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $289K in Q3 2019.
  • 159 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.